跳至主要内容
临床试验/NCT03801382
NCT03801382已完成不适用

Study to Establish the Psychometric Properties of the Digital Cognitive Tests on the Philips IntelliSpace Cognition Platform

Philips Electronics Nederland B.V. acting through Philips CTO organization2 个研究点 分布在 1 个国家目标入组 450 人开始时间: 2019年4月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
450
试验地点
2
主要终点
Scores Digital (ISC) Tests

研究概览

简要总结

This study aims to validate the tests that are on the IntelliSpace Cognition platform and to establish normative data for these tests.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Crossover
主要目的
Other
盲法
None

入排标准

年龄范围
50 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Examinee's primary language (language most often spoken) must be English.
  • If examinee has vision impairment or hearing loss, must be corrected to normal.
  • Must have normal fine and gross motor ability
  • Must have use of fingers, hands, and arms to be able to use a pencil to write symbols.
  • Must be able to understand subtest instructions and participate fully in testing.

排除标准

  • Evidence of current cognitive impairment.
  • Disruptive behavior or insufficient compliance with testing to ensure a valid assessment.
  • Examinee must not be currently admitted to a hospital, assisted living, nursing home or a psychiatric facility.
  • Examinee must not be diagnosed with a neurological disorder or disease (e.g., Parkinson's, brain tumor, stroke, TBI, epilepsy [if # seizures ≤ 2 and not receiving ongoing treatment for seizures, and not currently seeking medical evaluation or attention related to seizures, examinee can be accepted], encephalitis, dementia, language disorder (expressive or mixed receptive/expressive excluded; articulation disorder is ok), learning disorder.
  • Must not have been unconscious related to traumatic brain injury or "medical condition" > 20 minutes (however, e.g., heat stroke, medication induced are ok) or any head-injury resulting in an overnight hospital stay.
  • Any history of a medical event requiring resuscitation in which examinee was non-responsive for > 15 minutes.
  • Must not have current or recent functional change (ability to carry out usual duties at work, in school, IADLs [driving, shopping, managing money], etc.) due to cognitive change.
  • Examinee must not be receiving chemotherapy treatment, or have received chemotherapy treatment in the past 2 months.
  • Examinee must not have a history of ECT or radiation to the CNS.
  • Examinee must not be (currently or in the past) diagnosed with a psychotic disorder, or currently diagnosed with a mood disorder (however, Major Depressive Disorder in remission or with no current episode, and Dysthymic and Adjustment Disorders, are acceptable) or an anxiety disorder with symptoms significant enough to interfere with optimal test performance.
  • Autoimmune disorder (e.g., LUPUS, Multiple Sclerosis)
  • Examinee must not be currently diagnosed with substance abuse or dependence, or have carried any substance abuse or dependence diagnosis in the past year (> 1 year in remission diagnoses are ok). Long term alcohol abusers are excluded as well (e.g., abused substance for more than 10 years).
  • Any history of Autism Spectrum Disorder or Intellectual Disability.
  • The examinee must not be currently taking medication that might impact test performance (e.g., anti-convulsants, antipsychotics, benzodiazepines, psychostimulants, opiods, tricyclic antidepressants, some norepinephrine reuptake inhibitors). Most antihypertensive medications and statins are acceptable.
  • If previously diagnosed with any physical condition or illness that might depress test performance, illness must not interfere with normal cognitive functioning at work, school, ADLs, etc. Diabetes, hypothyroidism, and hypertension are acceptable if controlled.
  • Exclude primarily nonverbal or uncommunicative. Must not have a diagnosis of aphasia.
  • Examinees should not have received neuropsychological testing although previous MMSE testing is allowed if more than 6 months prior
  • Examinee must not be seeking medical diagnostic procedures for cognitive difficulties from a medical professional.
  • Non-valid health insurance in USA.

结局指标

主要结局

Scores Digital (ISC) Tests

时间窗: 1.5 hours

Scores retrieved from all cognitive tests on the ISC platform The cognitive tests included on the ISC platform are commonly used in neuropsychological assessments and measure aspects of executive functioning (TMT A, TMT B, Star Cancellation Test, RAVLT, Letter Fluency Test, Category Fluency Test, ROCFT, Digit Span Forward, Digit Span Backward), processing speed (Star Cancellation Test), working memory (TMT A, TMT B, Star Cancellation Test, Letter Fluency Test, Digit Span Forward, Digit Span Backward), memory (RAVLT), verbal processing (Letter Fluency Test, Category Fluency Test), and visual-spatial processing (RAVLT, ROCFT).

Scores From Paper Tests

时间窗: 1.5 hours

Scores from paper tests The paper cognitive tests included are the same as the tests included on the ISC platform are commonly used in neuropsychological assessments and measure aspects of executive functioning (TMT A, TMT B, Star Cancellation Test, RAVLT, Letter Fluency Test, Category Fluency Test, ROCFT, Digit Span Forward, Digit Span Backward), processing speed (Star Cancellation Test), working memory (TMT A, TMT B, Star Cancellation Test, Letter Fluency Test, Digit Span Forward, Digit Span Backward), memory (RAVLT), verbal processing (Letter Fluency Test, Category Fluency Test), and visual-spatial processing (RAVLT, ROCFT).

次要结局

未报告次要终点

研究者

发起方
Philips Electronics Nederland B.V. acting through Philips CTO organization
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验